A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...

CheckPoint is a weekly, half-hour investigative Current Affairs show featuring thought-provoking journalism. The programme brings together a team of seasoned television producers and investigative ...